Skip to main content

Caboxen 20 mg & 80 mg ( Cabozantinib)

Caboxen is identified as a cabozantinib product available in 20 mg and 80 mg strengths. Cabozantinib is an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class.

It is used in specific cancer-treatment settings to interfere with proteins involved in tumor growth, cancer-cell survival, and blood-vessel formation.

Taking cabozantinib correctly is important for treatment effectiveness and patient safety. Patients should follow their oncologist’s instructions, understand the administration requirements of their specific formulation, and attend regular medical appointments.

Important: Caboxen’s exact dosage form has not been independently confirmed. The instructions for cabozantinib tablets and capsules differ. Patients must confirm the formulation before following product-specific administration instructions.

1. Before Taking Caboxen

Before starting cabozantinib treatment, patients should undergo an appropriate medical assessment.

The prescribing oncologist may review:

  • Confirmed cancer diagnosis.
  • Cancer stage and progression.
  • Previous cancer treatments.
  • Medical and surgical history.
  • Existing liver or kidney problems.
  • Blood pressure.
  • Current prescription medicines.
  • Nonprescription medicines and supplements.
  • Pregnancy and breastfeeding considerations.
  • Previous adverse reactions to medicines.

Patients should inform their healthcare professional about all existing medical conditions.

This assessment helps determine whether cabozantinib is appropriate and which formulation and treatment regimen should be used.

2. Follow the Prescribed Dose

Cabozantinib dosage depends on the specific cancer, dosage form, treatment regimen, and individual patient factors.

The 20 mg and 80 mg strengths presented for Caboxen should not be interpreted as instructions for choosing a dose.

Established reference regimens differ by formulation and indication.

For example:

  • Cabozantinib tablets may be prescribed at 60 mg once daily for certain treatment indications.
  • Cabozantinib tablets may be prescribed at 40 mg once daily when combined with nivolumab for eligible patients with advanced renal cell carcinoma.
  • Cabozantinib capsules have a separate reference regimen for progressive metastatic medullary thyroid cancer.

These are reference-product regimens, not dosing recommendations for Caboxen.

Always take the medicine exactly as prescribed by the treating oncologist.

3. How to Take Cabozantinib Tablets

For the established CABOMETYX tablet formulation, the administration instructions include:

  1. Take the medicine according to the prescribed schedule.
  2. Take it on an empty stomach.
  3. Take it at least one hour before eating or at least two hours after eating.
  4. Swallow the tablet whole with water.
  5. Do not crush, chew, or split the tablet.
  6. Do not take additional tablets unless specifically prescribed.

These instructions apply to the reference tablet formulation and should not automatically be applied to Caboxen without confirmation of its dosage form.

4. How to Take Cabozantinib Capsules

For the established COMETRIQ capsule formulation, the administration instructions include:

  1. Follow the prescribed capsule dose.
  2. Avoid eating for at least two hours before taking the medicine.
  3. Take the capsules with water.
  4. Avoid eating for at least one hour after taking the medicine.
  5. Follow the prescribed daily schedule.

Capsule and tablet administration requirements are different.

Never substitute one formulation for another without specific instructions from the prescribing healthcare professional.

5. Should Caboxen Be Taken Before or After Food?

Food-related administration requirements depend on the formulation.

FormulationReference fasting requirement
Cabozantinib tabletsAt least 1 hour before food or 2 hours after food
Cabozantinib capsulesAt least 2 hours after food and 1 hour before the next meal

These instructions must not be combined or interchanged.

Patients should check the exact product information and follow their oncologist’s instructions.

6. Take Caboxen at a Consistent Time

Cabozantinib is generally prescribed on a regular daily schedule for the applicable treatment regimen.

Taking the medicine consistently can help patients maintain an organized treatment routine.

Patients should:

  • Follow the prescribed administration time.
  • Maintain the recommended fasting interval.
  • Avoid taking extra doses.
  • Keep track of missed doses.
  • Attend scheduled follow-up appointments.

If the prescribed schedule is unclear, ask the pharmacist or oncologist for clarification.

7. What to Do If You Miss a Dose

Missed-dose instructions depend on the specific formulation.

For the reference CABOMETYX tablet formulation, if the next dose is due within 12 hours, the missed dose should not be taken.

Patients should follow the missed-dose instructions for their actual product.

Important precautions:

  • Do not take two doses together to compensate.
  • Do not double the next dose.
  • Do not change the treatment schedule independently.
  • Contact a healthcare professional if unsure what to do.

8. What Happens If You Take Too Much Caboxen?

Taking more cabozantinib than prescribed may increase the risk of serious adverse reactions.

Possible concerns include:

  • Severe diarrhea.
  • Significant nausea and vomiting.
  • High blood pressure.
  • Liver abnormalities.
  • Severe fatigue.
  • Bleeding complications.
  • Other serious toxicities.

If an overdose is suspected, seek immediate medical advice.

Do not wait for symptoms to develop before requesting professional assistance.

9. Important Precautions While Taking Caboxen

Cabozantinib can cause serious complications that require regular monitoring.

Patients should understand the following precautions.

Blood Pressure

Cabozantinib may increase blood pressure.

Blood pressure should be checked before treatment and monitored regularly.

Bleeding

Cabozantinib may cause severe bleeding.

Report unusual bruising, blood in the urine, black stools, or other unexplained bleeding.

Diarrhea

Persistent or severe diarrhea can lead to dehydration.

Inform the healthcare professional if symptoms become difficult to manage.

Liver Function

Liver abnormalities may occur during treatment.

Follow the recommended blood-testing schedule.

Blood Clots

Cabozantinib may increase the risk of arterial and venous thromboembolic events.

Sudden chest pain, difficulty breathing, or one-sided leg swelling requires urgent medical assessment.

Wound Healing

Cabozantinib may interfere with normal wound healing.

Inform the oncologist before planned surgery or invasive dental procedures.

10. Medicines and Supplements to Avoid or Discuss

Cabozantinib may interact with other medicines through the CYP3A4 metabolic pathway.

Strong CYP3A4 inhibitors may increase cabozantinib exposure, while strong CYP3A4 inducers may decrease exposure.

Patients should tell their healthcare professional about:

  • Antibiotics.
  • Antifungal medicines.
  • Seizure medicines.
  • Other anticancer medicines.
  • Herbal products.
  • Vitamins.
  • Dietary supplements.
  • Nonprescription medicines.

Do not start, stop, or change another medicine without checking with a qualified healthcare professional.

11. Food and Lifestyle Considerations

Patients taking cabozantinib should follow the food-related instructions for their specific formulation.

General lifestyle considerations include:

  • Maintain an appropriate nutritional intake.
  • Drink adequate fluids according to medical advice.
  • Monitor unexpected weight changes.
  • Maintain appropriate oral hygiene.
  • Avoid activities that increase the risk of injury when experiencing significant weakness or dizziness.
  • Follow medical advice about physical activity.
  • Report persistent appetite changes.

Patients should ask their healthcare professional about grapefruit and grapefruit-containing products because they may affect CYP3A4 activity and cabozantinib exposure.

12. Taking Caboxen With Other Cancer Treatments

Cabozantinib may be prescribed alone or as part of a combination treatment regimen in selected cancer settings.

For example, cabozantinib tablets are used with nivolumab in eligible patients with advanced renal cell carcinoma.

Combination treatment may produce a different safety profile from cabozantinib monotherapy.

Patients should follow the complete treatment plan and report adverse reactions to their oncology team.

Never add another anticancer medicine without professional authorization.

13. Pregnancy and Breastfeeding Precautions

Cabozantinib may cause harm to an unborn baby.

Women who could become pregnant should discuss effective contraception with their healthcare professional.

Patients should also discuss:

  • Pregnancy planning.
  • Possible pregnancy during treatment.
  • Contraception after treatment.
  • Breastfeeding restrictions.

Breastfeeding is not recommended during treatment and for the specified period after the final dose under the applicable prescribing information.

14. Monitoring While Taking Caboxen

Regular monitoring helps healthcare professionals assess treatment effectiveness and identify adverse reactions.

Depending on the patient’s condition, monitoring may include:

Test or assessmentWhy it is important
Blood pressureDetect hypertension
Liver function testsIdentify liver abnormalities
Kidney functionEvaluate kidney health
Urine proteinDetect proteinuria
Blood testsMonitor relevant laboratory changes
Calcium levelsAssess electrolyte abnormalities
Thyroid functionMonitor thyroid-related changes
Skin examinationIdentify hand-foot reactions
Weight monitoringIdentify unexpected weight loss
Dental assessmentEvaluate oral health risks

The frequency of testing should be determined by the treating healthcare professional.

15. When Should Caboxen Be Temporarily Stopped?

The prescribing oncologist may recommend temporarily interrupting cabozantinib if a serious or intolerable adverse reaction develops.

Situations that may require treatment interruption include:

  • Severe hypertension.
  • Serious diarrhea.
  • Significant hand-foot skin reactions.
  • Severe liver abnormalities.
  • Proteinuria.
  • Serious bleeding.
  • Gastrointestinal perforation.
  • Fistula formation.
  • Other clinically significant complications.

Patients must never interrupt or restart treatment independently.

16. How to Store Caboxen

Storage conditions should follow the specific product’s official packaging instructions.

General precautions include:

  • Keep the medicine in its original packaging.
  • Store it according to the stated temperature requirements.
  • Protect it from excessive heat and moisture.
  • Keep it away from children and pets.
  • Avoid using expired medicine.
  • Do not use medicine with damaged or suspicious packaging.

Ask a pharmacist if the storage instructions are unclear.

17. Frequently Asked Questions About Taking Caboxen

1. How should Caboxen be taken?

Cabozantinib is an oral medicine. The exact administration instructions depend on the confirmed dosage form and prescribed treatment regimen.

2. Can I take Caboxen with food?

Food restrictions differ between tablet and capsule formulations. Follow the instructions for the exact product prescribed.

3. Should I take Caboxen every day?

Established cabozantinib treatment regimens commonly use once-daily administration, but the prescribed schedule must be confirmed by the treating oncologist.

4. Can I crush or chew Caboxen?

Do not crush or chew cabozantinib tablets. Confirm the handling instructions for the actual Caboxen formulation before use.

5. What should I do if I forget a dose?

Follow the missed-dose instructions for your specific formulation. Never double the next dose to compensate.

6. Can I take Caboxen with other medicines?

Some medicines may interact with cabozantinib. Inform your healthcare professional about all medicines and supplements before combining treatments.

7. Can I stop Caboxen when I feel better?

No. Treatment decisions should be made by the prescribing oncologist. Feeling better does not necessarily mean the cancer has stopped progressing.

8. Can Caboxen be taken during pregnancy?

Cabozantinib may cause fetal harm. Pregnancy prevention and treatment risks must be discussed with a healthcare professional.

9. What should I do if I experience severe side effects?

Contact your healthcare professional immediately. Seek emergency care for severe bleeding, chest pain, difficulty breathing, severe abdominal pain, or sudden neurological symptoms.

10. How long should I take Caboxen?

Treatment duration depends on the cancer type, treatment response, tolerability, and medical assessment. The oncologist determines how long therapy should continue.

Important Patient Guidance

Caboxen should only be taken according to a valid prescription and verified product-specific instructions.

The 20 mg and 80 mg strengths presented for Caboxen do not establish the correct treatment dose or dosage form.